Origo BiotechOrigo Biotech Pty Ltd
Overview
Origo Biotech is a biotechnology company that develops and markets plant genetic solutions to generic problems in agriculture. Origo Biotech works to take advantage of its proprietary gene discovery in plant growth and architecture, the timing of flowering and delayed ripening of the fruit to develop new ways to market.
Biotechnology company Origo mission ‘is to improve plant varieties through the introduction of high value-added features of modern Biotechnology to take advantage of international market requirements, with emphasis on tropical and subtropical crops and plantations.
Established in Brisbane, Australia, in 2003, Origo Biotech is an international management team and a research center based at the University of Queensland.
Number of employees
8
Company-specific approach
Investment / Marketing Partners.
The central business sense
Plant Biotechnology / Agriculture.
The competitive advantage
Niche marketing key international Biotechnology tropical and subtropical plants;
Key patents related to plant promoters, plant growth and architecture, the latter controls ripening fruit and flower development;
Proven experience in plant functional genomics, tissue culture and transformation of plants.
Partners
UniQuest Pty Ltd – Technology Consulting and Business, University of Queensland (www.uniquest.com.au). UniQuest provides management services and Origo Biotech Incubator.
University of Queensland – Origo Biotech has exclusive rights to patents developed by the Laboratory of Plant Genetic Resources Engineering (PGEL) within the School of Integrative Biology. The University of Queensland offers a Origo laboratory space for biotech.
Origo Investments – A venture capitalist firms owned by Spanish investors. Origo Origo Investments provides financing in biotech.
Competitive Advantages
Niche marketing key international Biotechnology tropical and subtropical plants;
Key patents related to plant promoters, plant growth and architecture, the latter controls ripening fruit and flower development;
Proven experience in plant functional genomics, tissue culture and transformation of plants.
Technology / IP
Origo Biotech is currently developing high value plants incorporating three proprietary technologies, including:
A new gene for delayed ripening of the fruit producers and consumers benefit by distributing the fruit to be transported and stored more time before it deteriorates;
A new gene for altered plant architecture to increase the aesthetic appeal to consumers and the agronomic value to farmers, providing plants with more branches and flowers, shorter and more compact growth, flowering time, and increased production of seeds;
An advocate of new plants at an extremely high level of constitutive expression and the licensing conditions that are more attractive compared to current industry standards;
A novel genetic means to regulate the timing of flowering and fruiting in tropical plantations.
Origo Biotech can also provide organizations with plant tissue culture and service changes.
Partnership Opportunities
Origo Biotech offers an excellent opportunity for strategic partners to take advantage of the growing market for transgenic seeds, which are now worth $ 5 billion dollars and growing at 15-20% per year.
Share access to services, and co-development agreement related to the commercialization of patented gene technology.
Partnership with the seeds of agricultural and international companies interested in developing the next generation of varieties of plants.
By providing licenses to organizations that discovered new genes of plants that require a marketing partner.
License outside of the organization with elite germplasm to test the amount of genetic variation in the population.
The organization needs
Origo Biotech is looking for partners who can offer a specific commitment, direct financial contributions to the intellectual property resources and other input, in exchange for commercial rights and access to new plants in new biotech traits, the potential for growth by investing to create alternative sources of funding and a higher profile in the industrial plant Biotechnology.
Origo Biotech is interested in partnering with companies that may have a new plant varieties in the market, and to complement the patented technology of Origo Biotech. Key markets: Asian, Indian, Pacific, Central and South America.